🌿𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗔𝗻𝗼𝘁𝗵𝗲𝗿 𝗠𝗮𝗷𝗼𝗿 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗶𝗻 𝗖𝗮𝗻𝗻𝗮𝗯𝗶𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: 𝗧𝗵𝗲 𝗦𝗖𝗥𝗜𝗣𝗧 𝗣𝗶𝗹𝗼𝘁 𝗣𝗿𝗼𝗷𝗲𝗰𝘁🌿
🎉We are thrilled to announce another significant milestone in THC cannabis research. Pure Production AG, a member of the Pure Group, is the exclusive cannabis producer for the groundbreaking SCRIPT pilot project.
🔬𝗔𝗯𝗼𝘂𝘁 𝗦𝗖𝗥𝗜𝗣𝗧: The “Safer Cannabis Research In Pharmacies randomized controlled Trial” (SCRIPT), spearheaded by the University of Bern in collaboration with the University of Lucerne and the cities of Bern, Biel, and Lucerne, has been greenlit by Swiss health and ethics authorities. This study, starting in autumn 2023, is not just a research initiative but a step forward in understanding the health and social impacts of regulated cannabis sales.
🏛️ 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗖𝗼𝗻𝘁𝗲𝘅𝘁: SCRIPT is a vital part of the Swiss government’s exploratory efforts under the revised narcotics law that permits controlled non-medical cannabis distribution studies. It uniquely focuses on a non-profit model with cannabis sourced from Switzerland under organic regulations, highlighting our commitment to quality and regulatory compliance.
👥 𝗦𝘁𝘂𝗱𝘆 𝗦𝗰𝗼𝗽𝗲: Set in Bern, Biel, and Lucerne, SCRIPT aims to involve about 1,000 regular recreational cannabis users over 18. The randomized control approach, wherein only half the participants can buy regulated cannabis products from pharmacies in the first six months, ensures reliable data. This method, along with the study’s emphasis on public health, youth protection, and public safety, distinguishes SCRIPT from other pilot projects.
💡𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗔𝗰𝘁𝗶𝗼𝗻: Participants will have access to various cannabis products, including flowers, hashish, e-liquids, and tinctures, all produced in Switzerland by Pure Production AG and Puregene AG under stringent quality controls and bio-regulations. This initiative not only showcases our dedication to quality and innovation but also emphasizes our role in shaping the future of cannabis in Europe.
🌱 𝗣𝘂𝗿𝗲 𝗚𝗿𝗼𝘂𝗽’𝘀 𝗥𝗼𝗹𝗲: As Europe’s first legal recreational THC cannabis producer, Pure Production AG is proud to contribute to this innovative study. Our journey from ‘Seed to Sale’ reflects our dedication to pioneering cannabis research, cultivation, and distribution. We are honored to play a pivotal role in SCRIPT, supporting efforts to inform future cannabis regulations and improve public health and safety.